December 12, 2014 - 1:30 PM - 2:30 PM ET

"Canada's IP Guidelines and Perspective on Pharmaceutical Issues" for the ABA Antitrust Program

This event has already occurred.

The panel will discuss the Canadian Competition Bureau's Updated Intellectual Property Enforcement Guidelines and approach to pharmaceutical issues, including reverse payments and product hopping. The discussion will compare and contrast the Canadian approach with that of the U.S. antitrust agencies and courts.

Leigh Oliver, Hogan Lovells

Alan Gunderson, Canadian Competition Bureau
Robert Davis, Esq., Venable LLP
Navin Joneja, Blakes
Michael Kades, Federal Trade Commission

For more information, please visit the American Bar Association website.